Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 13:36:17 UTC
Update Date2021-09-26 23:08:17 UTC
HMDB IDHMDB0254344
Secondary Accession NumbersNone
Metabolite Identification
Common NameMasitinib
DescriptionMasitinib, also known as AB 1010 or kinavet ca-1, belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. Based on a literature review a significant number of articles have been published on Masitinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Masitinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Masitinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
AB 1010ChEBI
AB-1010ChEBI
AB1010ChEBI
4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamideMeSH
Kinavet ca-1MeSH
MasatinibMeSH
Masitinib mesylateMeSH
MasivetMeSH
MasitinibMeSH
Chemical FormulaC28H30N6OS
Average Molecular Weight498.65
Monoisotopic Molecular Weight498.220180784
IUPAC NameN-(4-methyl-3-{[4-(pyridin-3-yl)-2,3-dihydro-1,3-thiazol-2-ylidene]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide
Traditional NameN-(4-methyl-3-{[4-(pyridin-3-yl)-3H-1,3-thiazol-2-ylidene]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide
CAS Registry NumberNot Available
SMILES
CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(N=C3NC(=CS3)C3=CN=CC=C3)=C(C)C=C2)CC1
InChI Identifier
InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)
InChI KeyWJEOLQLKVOPQFV-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassAnilides
Direct ParentBenzanilides
Alternative Parents
Substituents
  • Benzanilide
  • Diaminotoluene
  • Benzamide
  • Benzoic acid or derivatives
  • Phenylmethylamine
  • Aniline or substituted anilines
  • Benzylamine
  • Benzoyl
  • 2,4-disubstituted 1,3-thiazole
  • Aralkylamine
  • N-alkylpiperazine
  • N-methylpiperazine
  • Toluene
  • Piperazine
  • 1,4-diazinane
  • Pyridine
  • 1,3-thiazol-2-amine
  • Azole
  • Thiazole
  • Heteroaromatic compound
  • Amino acid or derivatives
  • Carboxamide group
  • Tertiary aliphatic amine
  • Tertiary amine
  • Secondary carboxylic acid amide
  • Organoheterocyclic compound
  • Carboxylic acid derivative
  • Azacycle
  • Secondary amine
  • Organonitrogen compound
  • Amine
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organooxygen compound
  • Organic nitrogen compound
  • Organic oxygen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.64ALOGPS
logP3.85ChemAxon
logS-4.6ALOGPS
pKa (Strongest Acidic)9.52ChemAxon
pKa (Strongest Basic)8.17ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area72.86 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity152.37 m³·mol⁻¹ChemAxon
Polarizability56.01 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+211.13930932474
DeepCCS[M-H]-208.74330932474
DeepCCS[M-2H]-241.62630932474
DeepCCS[M+Na]+217.05130932474
AllCCS[M+H]+223.332859911
AllCCS[M+H-H2O]+221.532859911
AllCCS[M+NH4]+224.932859911
AllCCS[M+Na]+225.332859911
AllCCS[M-H]-206.832859911
AllCCS[M+Na-2H]-207.432859911
AllCCS[M+HCOO]-208.232859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
MasitinibCN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(N=C3NC(=CS3)C3=CN=CC=C3)=C(C)C=C2)CC15408.2Standard polar33892256
MasitinibCN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(N=C3NC(=CS3)C3=CN=CC=C3)=C(C)C=C2)CC14415.0Standard non polar33892256
MasitinibCN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(N=C3NC(=CS3)C3=CN=CC=C3)=C(C)C=C2)CC15137.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Masitinib,1TMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS14495.3Semi standard non polar33892256
Masitinib,1TMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS12868.8Standard non polar33892256
Masitinib,1TMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS15683.1Standard polar33892256
Masitinib,1TMS,isomer #2CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C4677.9Semi standard non polar33892256
Masitinib,1TMS,isomer #2CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C3179.2Standard non polar33892256
Masitinib,1TMS,isomer #2CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C5783.5Standard polar33892256
Masitinib,2TMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C4378.2Semi standard non polar33892256
Masitinib,2TMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C2991.9Standard non polar33892256
Masitinib,2TMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C5468.5Standard polar33892256
Masitinib,1TBDMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS14632.9Semi standard non polar33892256
Masitinib,1TBDMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS13112.8Standard non polar33892256
Masitinib,1TBDMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1[NH]C(C2=CC=CN=C2)=CS15723.3Standard polar33892256
Masitinib,1TBDMS,isomer #2CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C4810.3Semi standard non polar33892256
Masitinib,1TBDMS,isomer #2CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C3448.8Standard non polar33892256
Masitinib,1TBDMS,isomer #2CC1=CC=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C5802.6Standard polar33892256
Masitinib,2TBDMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C4679.8Semi standard non polar33892256
Masitinib,2TBDMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C3546.6Standard non polar33892256
Masitinib,2TBDMS,isomer #1CC1=CC=C(N(C(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)[Si](C)(C)C(C)(C)C)C=C1N=C1SC=C(C2=CC=CN=C2)N1[Si](C)(C)C(C)(C)C5506.2Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Masitinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-00r2-8963300000-2d593c28d5db8989cb5a2021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Masitinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Masitinib LC-ESI-qTof , Positive-QTOFsplash10-0002-0236920000-165320b13f69ca2a3a292017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Masitinib , positive-QTOFsplash10-0udi-1291000000-f2e2f823b1870c00bb6d2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Masitinib , positive-QTOFsplash10-0002-0236920000-165320b13f69ca2a3a292017-09-14HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 10V, Positive-QTOFsplash10-0002-0144900000-9c6dbca381a41aae5bf82017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 20V, Positive-QTOFsplash10-014j-0589300000-19a7a8c539240afd7b792017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 40V, Positive-QTOFsplash10-014r-3920000000-6f3dbd39f4906a1624022017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 10V, Negative-QTOFsplash10-0002-2401900000-ab941bcb0b26ca88ff2c2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 20V, Negative-QTOFsplash10-000b-6826900000-b4896718b46f09d230362017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 40V, Negative-QTOFsplash10-0gzc-8900000000-ce88d8a1c827d14510212017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 10V, Positive-QTOFsplash10-0002-0001900000-101222712422fd7438842021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 20V, Positive-QTOFsplash10-0002-0319200000-ece5f888ca4a96242c762021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 40V, Positive-QTOFsplash10-01b9-3913300000-db838cfd1ed69e4ec4be2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 10V, Negative-QTOFsplash10-0002-0001900000-394dbea5938dd91d535b2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 20V, Negative-QTOFsplash10-0002-0216900000-5eee9c5baf9c6b2f40452021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Masitinib 40V, Negative-QTOFsplash10-001l-1323900000-0e4400a5ea70ea7a10c42021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11526
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8250179
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkMasitinib
METLIN IDNot Available
PubChem Compound10074640
PDB IDNot Available
ChEBI ID63450
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]